Metraipolis › archive › dc_6197ef8ed589

Facilitated DNA damage repair as an emerging therapeutic strategy for inflammatory and fibrotic diseases — Europe PMC PMID:41918628

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41918628
DOI
10.1039/d5cb00327j
License (as archived)
solo-consultazione
Archived
2026-11-04T02:43:24.769Z
SHA-256 of the archived text
6b902b6679b166d948851a83bd1d143992111265afeaae634fc1337daca02f14
Stable URL of this page
https://metraipolis.com/documento/dc_6197ef8ed589

How to cite

Facilitated DNA damage repair as an emerging therapeutic strategy for inflammatory and fibrotic diseases — Europe PMC PMID:41918628 — Europe PMC (en), https://europepmc.org/article/MED/41918628 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_6197ef8ed589 (Metraipolis archive dc_6197ef8ed589, sha256 6b902b6679b166d948851a83bd1d143992111265afeaae634fc1337daca02f14)
BibTeX
@misc{dc6197ef8ed589,
  title = {Facilitated DNA damage repair as an emerging therapeutic strategy for inflammatory and fibrotic diseases — Europe PMC PMID:41918628},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41918628},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_6197ef8ed589; sha256 6b902b6679b166d948851a83bd1d143992111265afeaae634fc1337daca02f14},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41918628. Agents can read the archived copy with the MCP tool read_document.